Key result
Type D personality independently predicted poorer medication adherence in patients with Type 2 diabetes mellitus, significantly reducing adherence scores by 1.48 points compared to those without Type D personality.
Why the study?
Does Type D personality predict poor medication adherence in patients with Type 2 Diabetes Mellitus?
Cohort (n=412)
No
Does Type D personality predict poor medication adherence in patients with Type 2 Diabetes Mellitus?
Type D personality, when assessed as a categorical variable, predicts poor medication adherence in Chinese patients with Type 2 Diabetes Mellitus, suggesting a potential target for adherence interventions.
Answers are grounded in this paper and cite their sources.
Type D personality may flag adherence risk in T2DM; hypothesis-generating for interventions as causal effects remain unproven.
BACKGROUND: Type D personality and medication nonadherence have been shown to be associated with poor health outcomes. Type D personality is associated with poor medication adherence in patients with coronary artery disease, myocardial infarction, and heart failure. However, the relationship between type D personality and medication adherence in patients with Type 2 Diabetes Mellitus (T2DM) remains unknown. This study aims to examine whether type D personality was associated with medication adherence in patients with T2DM. DESIGN AND SETTINGS: A follow-up study was conducted in general hospital of the People's Liberation Army in Beijing. METHODS: 412 T2DM patients (205 females), who were recruited by circular systematic random sampling, provided demographic and baseline data about medical information and completed measures of Type D personality. Then, 330 patients went on to complete a self-report measure of medication adherence at the sixth month after baseline data collection. Chi-square test, t tests, and hierarchical multiple regression analyses were conducted, as needed. RESULTS: Patients with type D personality were significantly more likely to have poor medication adherence (p<0.001). Type D personality predicts poor medication adherence before and after controlling for covariates when it was analyzed as a categorical variable. However, the dimensional construct of type D personality was not associated with medication adherence when analyzed as a continuous variable. CONCLUSION: Although, as a dimensional construct, type D personality may not reflect the components of the personality associated with poor medication adherence in patients with T2DM, screening for type D personality may help to identify those who are at higher risk of poor medication adherence. Interventions, aiming to improve medication adherence, should be launched for these high-risk patients.
No takes yet. Share an insight, caveat, or question.
Li et al. (2016) conducted a cohort in Type 2 Diabetes Mellitus (n=412). Type D personality vs. Non-Type D personality was evaluated on Medication adherence (MMAS-8 score) (β -1.48, 95% CI -1.93, -1.03, p=<0.0001). Type D personality independently predicted poorer medication adherence in patients with Type 2 diabetes mellitus, significantly reducing adherence scores by 1.48 points compared to those without Type D personality.
Synapse has enriched 10 related papers. Consider them for comparative context: